The FDA sent out an update on November 1 regarding drugs that are currently in shortage:
- Bleomycin Sulfate for Injection (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Cefepime Injection (Updated – Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Cyclophosphamide Tablets (New – Discontinuation)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Tobramycin Injection (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
